Does Lymphadenectomy Improve Survival in Uterine Leiomyosarcoma?

Tasci T., Karalok A., TAŞKIN S., Ureyen I., Kimyon G., Tulek F., ...More

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol.25, no.6, pp.1031-1036, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 6
  • Publication Date: 2015
  • Doi Number: 10.1097/igc.0000000000000452
  • Journal Name: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1031-1036
  • Keywords: Uterine leiomyosarcoma, Lymph node dissection, Prognosis, ENDOMETRIAL STROMAL SARCOMA, GYNECOLOGIC-ONCOLOGY-GROUP, SMOOTH-MUSCLE TUMORS, PROGNOSTIC-FACTORS, LYMPH-NODE, STAGE-I, ADJUVANT CHEMOTHERAPY, UTERUS, VALIDATION, METASTASES
  • Ankara University Affiliated: Yes

Abstract

Introduction The role of lymphadenectomy in the management of uterine leiomyosarcoma (LMS) is controversial. We aimed to identify whether lymph node dissection (LND) has any survival benefit in uterine LMS.